IRulya Therapeutics Inc. (IRLA) — research page
US · us-cm-kg/NASDAQ/IRLA · as of 2026-11-08
Identity and listing
The issuer is IRulya Therapeutics Inc., listed on NASDAQ under ticker IRLA, with ISIN US22053A3059. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | IRulya Therapeutics Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | IRLA | source · 2026-11-08 |
| ISIN | US22053A3059 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 80 filings in the twelve months to 2026-11-08, across 47 filing days. The median gap between filing days is 5.0 days. The latest filing is dated 2026-11-05, 3 days before the record date, and is of type regulatory_filing. The NASDAQ exchange median is 6.0 days for cadence gap, 52 filings and 5.0 days latency across 4,359 issuers. The sector median is 5.5 days for cadence gap, 65.5 filings and 4.0 days latency across 176 issuers. The window holds 21 regulatory_filing, 21 directors_dealings, 9 corporate_news, 7 agm_egm, 7 director_change, 7 results, 3 ad_hoc, 2 halt_suspension, 2 prospectus and 1 takeover filing.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 80 | 5 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | regulatory_filing | 144 | 144 |
| 2026-10-21 | regulatory_filing | 144 | 144 |
| 2026-10-19 | directors_dealings | 3 | 3 |
| 2026-10-19 | directors_dealings | 3 | 3 |
| 2026-10-19 | directors_dealings | 3 | 3 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is BDO USA, P.C., located in San Jose, California. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read. The count is 0.
Open research
No openly published research notes were found on the record. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001662774.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/IRLA (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1662774/000119312526151364/qncx-20251231.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/IRLA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US22053A3059"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:76eb8197d5ba297e.